Arnon Nagler
阿尔农·纳格勒
MD, MSc
Head, Hematology and Bone Marrow Transplantation Division血液学与骨髓移植科主任
👥Biography 个人简介
Arnon Nagler leads one of the world's most active transplant programs at Sheba Medical Center, with seminal contributions to haploidentical HSCT, GvHD prevention strategies, and international collaborative outcomes research through EBMT.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Haploidentical HSCT Innovation
Pioneered haploidentical transplantation protocols at Sheba, including T cell-replete approaches with PT-Cy, enabling transplant access for patients lacking matched donors and achieving outcomes comparable to matched donor transplants.
EBMT Collaborative Research
Served as senior investigator for landmark EBMT registry studies comparing transplant platforms, conditioning regimens, and GvHD strategies across European centers, producing practice-defining evidence.
Representative Works 代表性著作
Comparison of outcomes after haploidentical vs matched unrelated donor transplantation for relapsed/refractory AML
Leukemia (2022)
EBMT registry analysis showing comparable outcomes between haplo and MUD transplantation for high-risk AML.
Post-transplantation cyclophosphamide-based haploidentical transplantation for adult patients with ALL
Blood Advances (2021)
Multi-center study demonstrating efficacy of PT-Cy haplo approach in ALL, supporting its broad adoption.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 阿尔农·纳格勒 的研究动态
Follow Arnon Nagler's research updates
留下邮箱，当我们发布与 Arnon Nagler（Sheba Medical Center, Tel Hashomer / Tel Aviv University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment